Warfarin-induced deep vein thrombosis.

Paradoxical Procoagulant Effect of Early Doses of Warfarin: Possible Role of Non-Vitamin K Oral Anticoagulant in Patients with Atrial Fibrillation-Related Stroke. J Stroke (2015) 0.83

Stent thrombosis caused by metal allergy complicated by protein S deficiency and heparin-induced thrombocytopenia: a case report and review of the literature. Thromb J (2015) 0.75

Quantitative Systems Pharmacology Model to Predict the Effects of Commonly Used Anticoagulants on the Human Coagulation Network. CPT Pharmacometrics Syst Pharmacol (2016) 0.75

A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther (1981) 69.83

Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.88

Guidelines on oral anticoagulation with warfarin - fourth edition. Br J Haematol (2011) 4.98

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J (2001) 3.34

A warfarin induction regimen for out-patient anticoagulation in patients with atrial fibrillation. Br J Haematol (1998) 1.63

Warfarin induced skin necrosis. Br J Surg (2000) 1.57

A new regimen for starting warfarin therapy in out-patients. Br J Clin Pharmacol (1998) 1.12

Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest (1995) 1.05

Warfarin-induced skin necrosis associated with Factor V Leiden and protein S deficiency. Clin Lab Haematol (2001) 0.83